Gemcitabine-based combination treatment of pancreatic cancer

被引：44
|
作者：
Heinemann, V [1 ]
机构：
[1] Klinikum Grosshadern, Med Clin 3, D-81377 Munich, Germany
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30749
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 35
页数：11
相关论文
共 50 条
  • [31] Gemcitabine-based chemoradiotherapy gets improved with PARP inhibitor in pancreatic cancer cells
    Waissi, W.
    Burckel, H.
    Magisson, E.
    Larderet, G.
    Noel, G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S545 - S545
  • [32] Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?
    Hao, Fulong
    Chen, Xinyang
    Li, Hancong
    Feng, Qingbo
    Hou, Yong
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (01) : 478 - 479
  • [33] Gemcitabine-based combinations in non resectable pancreatic adenocarcinoma
    Louvet, C
    André, T
    Artru, P
    BULLETIN DU CANCER, 2002, 89 : S96 - S101
  • [34] Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection The Indiana University Experience
    Khawaja, Muhammad R.
    Kleymau, Svetlana
    Yu, Zhangsheng
    Howard, Thomas
    Burns, Matthew
    Nakeeb, Attila
    Loehrer, Patrick J.
    Cardenes, Higinia R.
    Chiorean, Elena Gabriela
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (01): : 42 - 46
  • [35] Pancreatic Cancer Cell Genetics and Signaling Response to Treatment Correlate with Efficacy of Gemcitabine-Based Molecular Targeting Strategies
    Bryan Holcomb
    Michele T. Yip-Schneider
    Jesus M. Matos
    Jennifer Dixon
    Jason Kennard
    Julie Mahomed
    Rajasubramaniam Shanmugam
    Judith Sebolt-Leopold
    C. Max Schmidt
    Journal of Gastrointestinal Surgery, 2008, 12 : 288 - 296
  • [36] Role of concurrent gemcitabine-based chemoradiation and regional nodal irradiation in the treatment of locally advanced pancreatic cancer - Response
    Li, CP
    Chao, Y
    Yen, SH
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 1009 - 1010
  • [37] Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma
    Piquemal, David
    Bruno, Roman
    Bournet, Barbara
    Ghiringhelli, Francois
    Noguier, Florian
    Canivet, Cindy
    Bertaut, Aurelie
    Pierrat, Fabien
    Evesque, Ludovic
    Gamez, Amelia
    Cros, Jerome
    Rederstorff, Emilie
    Petit, Erwan
    Adnet, Johan
    Saint, Angelique
    Drouillard, Antoine
    Kempf, Emmanuelle
    Soularue, Emilie
    Vincent, Julie
    Baumgaertner, Isabelle
    Hennequin, Audrey
    Tournigand, Christophe
    Ataz, Daniel Lopez Trabada
    Bengrine, Leila
    Lepage, Come
    Manfredi, Sylvain
    Afchain, Pauline
    Trouilloud, Isabelle
    Gagnaire, Alice
    LoConte, Noelle K.
    Bachet, Jean-Baptiste
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (02) : 997 - +
  • [38] The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy
    Passero, Frank C., Jr.
    Grapsa, Dimitra
    Syrigos, Kostas N.
    Saif, Muhammad Wasif
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 697 - 703
  • [39] Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies
    Holcomb, Bryan
    Yip-Schneider, Michele T.
    Matos, Jesus M.
    Dixon, Jennifer
    Kennard, Jason
    Mahomed, Julie
    Shanmugam, Rajasubramaniam
    Sebolt-Leopold, Judith
    Schmidt, C. Max
    JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (02) : 288 - 296
  • [40] Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Tsujino, Takeshi
    Kogure, Hirofumi
    Yagioka, Hiroshi
    Yashima, Yoko
    Togawa, Osama
    Arizumi, Toshihiko
    Matsubara, Saburo
    Hirano, Kenji
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 252 - 259
12345